Based on the Wall Street analyst consensus for 84 of TDNA’s holdings.
TDNA 12 Month Forecast
Average Price Target
$39.17▲(58.16% Upside)
Based on Wall Street analyst 12-month price targets for 84 of T. Rowe Price Biotech ETF’s holdings in the last 3 months. The average price target is $39.17 with a high forecast of $49.93 and a low forecast of $27.05. The average price target represents a 58.16% change from the last price of $24.77.
Past 12 Months12 Month ForecastOct2026Nov2026
High$49.93
Average$39.17
Low$27.05
Past 12 Months12 Month Forecast$23$29.8$36.5$43.3$50Oct2026Oct2026Nov2026Nov2026Nov2027
What is TDNA’s average 12-month price target, according to analysts?
Based on Wall Street analyst price targets for 84 of TDNA’s holdings, T. Rowe Price Biotech ETF’s 12-month average price target is $39.17.
What is TDNA’s upside potential, based on the analysts’ average price target?
TDNA’s average price target of $39.17 represents a 58.16% upside from its last price of $24.77.
Is TDNA a Buy, Sell or Hold?
T. Rowe Price Biotech ETF has a consensus rating of Strong Buy, based on the analyst consensus for 84 of TDNA’s holdings: 83 rated Buy, 1 rated Hold and 0 rated Sell.
What is T. Rowe Price Biotech ETF’s price target?
The average price target for T. Rowe Price Biotech ETF is $39.17, based on Wall Street analyst 12-month price targets for 84 of TDNA’s holdings, issued in the past 3 months. The highest price target is $49.93 and the lowest is $27.05. The average price target represents a 58.16% increase from the last price of $24.77.
What is TDNA’s expense ratio?
TDNA’s expense ratio is 0.55%.
How many holdings does TDNA have?
TDNA holds 87 assets.
How can I buy shares of TDNA?
You can buy shares of TDNA through a brokerage account. Compare brokers on our Best Online Brokers page.